miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).

X, He; SY, Chen; Z, Yang; J, Zhang; W, Wang; MY, Liu; Y, Niu; XM, Wei; HM, Li; WN, Hu; GG, Sun

doi:10.1186/s13046-018-0882-4

Public

miR-4317 suppresses non-small cell lung cancer (NSCLC) by targeting fibroblast growth factor 9 (FGF9) and cyclin D2 (CCND2).

Shared by NobleBlocks on Sep 18, 2018 • 12:00 AM UTC

Authors:

He X

Chen SY

Yang Z

Abstract

<h4>Background</h4>Non-small cell lung cancer (NSCLC) is a leading cause of death worldwide. MicroRNAs (miRNAs) have been indicated as crucial actors in cancer biology. Accumulating evidence suggests that miRNAs can be used as diagnostic and prognostic markers for NSCLC.<h4>Methods</h4>The purpose o...

Subject

Metastasis

Non-small cell lung cancer

therapeutic target

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!